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Abstract 
 Voltage-gated calcium (Ca2+) channels provide the pathway for Ca2+ influxes that 
underlie Ca2+-dependent responses in muscles, nerves, and other excitable cells. They are also 
targets of a wide variety of drugs and toxins. Ca2+ channels are multisubunit protein complexes 
consisting of a pore-forming α1 subunit and other modulatory subunits, including the β subunit. 
Here, we review the structure and function of schistosome Ca2+ channel subunits, with particular 
emphasis on variant Ca2+ channel β subunits (Cavβvar) found in these parasites. In particular, we 
examine the role these β subunits may play in the action of praziquantel, the current drug of 
choice against schistosomiasis. We also present evidence that Cavβvar homologs are found in 
other praziquantel-sensitive platyhelminths such as the pork tapeworm, Taenia solium, and that 
these variant β subunits may thus represent a platyhelminth-specific gene family. 
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1. Introduction 
 Diseases caused by platyhelminthic parasites represent a worldwide health crisis.  
Schistosomiasis, caused by trematode flatworms of the genus Schistosoma, affects approximately 
200 million people, killing as many as 280,000 people per year (van der Werf et al., 2003), with 
a large percentage of infected individuals residing in Africa (Engels et al., 2002; Chitsulo et al., 
2004). Cestodes of the genus Taenia and other platyhelminths infect millions more. The drug of 
choice against platyhelminthic parasites is praziquantel, a compound that is generally ineffective 
against parasites from other phyla. The platyhelminth-specific efficacy of praziquantel remains 
unexplained, as its mode of action at the cellular and molecular level is not yet fully understood. 
Recent evidence suggests that voltage-gated Ca2+ channels (VGCCs) in schistosomes possess a 
subunit with an unusual structure that may underlie their sensitivity to praziquantel. Here we will 
focus on the structure and function of VGCCs in platyhelminths and present new data 
demonstrating that the variant VGCC form found in schistosomes is shared by other classes of 
platyhelminths. 
 
2. Voltage-gated Ca2+ channels 
 VGCCs belong to the superfamily of voltage-gated ion channels that respond to changes 
in membrane potential by selectively allowing ions to flow down their electrochemical gradient. 
VGCCs play a unique role within this family by coupling changes in membrane potential to the 
influx of Ca2+ necessary to elicit intracellular signaling (reviewed by Catterall, 2000; Hofmann et 
al., 1999). In addition to propagating impulses, VGCCs gate the Ca2+ influx that underlies 
excitation-contraction coupling, excitation-secretion coupling, and other Ca2+-dependent 
processes. The importance of VGCCs to cellular function is underscored by their role as targets 
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for both therapeutic drugs and components of venoms used by a wide variety of predators. 
 VGCCs comprise a pore-forming α1 subunit and smaller auxiliary subunits known as β,  
α2δ, and γ (Fig. 1).  Although the α1 subunit largely determines both the pharmacology of the 
channel and the nature of the current gated by it, the auxiliary subunits play important roles in 
shaping the response of the channel. The α1 subunit contains four homologous domains, 
connected by intracellular loops, that form the sides of the membrane pore (Doyle et al., 1998).  
Each domain includes six transmembrane segments (labeled S1-S6), with the S4 segment 
containing positively charged residues that act as a voltage sensor and the extracellular P-loop 
between S5 and S6 determining the ion selectivity of the channel. 
 The currents gated by VGCCs are divided into high voltage-activated (HVA) and low 
voltage-activated (LVA) currents, defined by the membrane potential at which the channels 
open. HVA currents have been further divided on the basis of pharmacological response. L-type 
HVA currents are sensitive to classical organic Ca2+ channel blockers such as nifedipine, 
verapamil, and diltiazem. Non-L-type HVA currents include N-type, P/Q-type, and R-type 
currents, each insensitive to the L-type channel blockers, but distinguished by selective 
sensitivity to particular toxins. 
 Physiological and pharmacological distinctions between VGCCs are mirrored in the 
molecular variation among α1 subunits. Phylogenetic analysis divides α1 subunits into three 
clusters known as Cav1, Cav2, and Cav3, which correspond to L-type, non-L-type, and LVA 
channels, respectively (Catterall et al., 2005). Although mammals and other vertebrates possess 
three or four subtypes of each channel type differing in tissue and subcellular distribution, only 
single genes for each type are found in the invertebrate species that have been studied. For 
example, thorough analysis of the fully sequenced genomes of Caenorhabditis elegans and 
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Drosophila melanogaster has revealed one homolog each of Cav1, Cav2, and Cav3 α1 subunits, 
each of which presumably fulfills the roles taken by multiple gene products in mammalian 
tissues. 
 A further source of variation in VGCC currents is the influence of auxiliary subunits, of 
which the β subunit has been most extensively studied (reviewed by Walker & DeWaard, 1998; 
Birnbaumer et al., 1998; Hanlon & Wallace, 2002; Dolphin, 2003; Richards et al., 2004). The β 
subunit is a cytoplasmic protein that has four subtypes in vertebrates, but only single homologs 
in most invertebrate species. The β subunit increases current density and ligand binding to the α1 
subunit, in part by masking an endoplasmic reticulum retention signal on the α1 subunit, 
enhancing its trafficking to the plasma membrane. β subunits also modulate various kinetic 
properties of the channel, such as the voltage-dependence of activation and inactivation, the rate 
of inactivation, and recovery from inactivation. 
 The primary site on the α1 subunit for interaction with the β subunit is a region of the 
intracellular loop between domains I and II labeled the alpha interaction domain (AID). Early 
studies described a similarly conserved site in the β subunit, the 30-residue β interaction domain 
(BID; DeWaard et al., 1994). Subsequent work has resolved the crystal structure of the 
conserved core of the β subunit, both alone and complexed with the AID of the α1 subunit (Chen 
et al., 2004; Opatowski et al., 2004; Petegem et al., 2004; commentary by Yue, 2004). These 
studies have verified the prediction (Hanlon et al., 1999) that Cavβs are members of the 
membrane-associated guanylate kinase (MAGUK) family of proteins. MAGUKs are often 
concentrated at synapses and are thought to play important roles in clustering ion channels and 
neurotransmitter receptors (reviewed by Dimitratos et al., 1999). MAGUK proteins typically 
comprise one or more PDZ domains (Ponting et al., 1997) located N-terminally to a Src-
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homology 3 (SH3) domain, a bridging region (the HOOK domain), and a guanylate kinase (GK)-
like domain. Cavβs differ from other members of the MAGUK family in important respects, 
lacking the N-terminal PDZ domains and a nucleotide binding site within the GK domain. 
 Although the newly revealed crystal structure of β subunits indicates that the AID of the 
α1 subunit binds not to the BID, but within the modified GK domain, the BID plays an essential 
structural role in β subunits (Chen et al., 2004). It spans the SH3 and GK domains and the 
connecting HOOK region, contains two β-strands that are integral parts of the SH3 and GK 
domains, and may be necessary for proper folding of the β subunit. 
 Most of the heterologous characterization of α1 and β subunits has been conducted with 
genes cloned from mammalian species.  Mammalian subunits were the first cloned, and many 
invertebrate homologs that were subsequently identified were not as amenable to expression in 
heterologous expression systems.  Until molecular biological approaches began to be applied in 
recent years to studying helminthic Ca2+ currents, their direct characterization depended upon 
electrophysiological recordings, which are technically difficult in flatworms.  For example, 
although Ca2+ influx has been implicated in contractility, no native Ca2+ currents from 
schistosome cells have yet been published, though a preliminary report has indicated that these 
currents can be found in muscle fibers (Cobbett and Day, 2002), along with previously described 
K+ currents (Day et al., 1993). Some information on native Ca2+ currents has been gained from 
experiments in other platyhelminths, but pharmacological characterization has proved 
challenging, which is one reason why the molecular target of praziquantel (see below) remains 
undefined (for review see Greenberg, 2005). 
 
3. Voltage-gated Ca2+ channel subunits in schistosomes 
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 Molecular cloning approaches have now begun to clarify the structure and functional 
properties of schistosome VGCC subunits (Kohn et al., 2001a, b; reviewed by Greenberg, 2005). 
Three full-length HVA α1 subunits have been cloned from adult S. mansoni. Although none has 
yet been heterologously expressed, two can be classified as non-L-type α1 subunits and one as L-
type based on sequence similarity to mammalian proteins (Kohn et al., 2001b). The presence of 
two non L-type α1 subunits in schistosomes is unusual. In other invertebrates that have been 
examined, including several complete invertebrate genomes, only single L-type and non L-type 
α1 subunits are found (Littleton and Ganetzky, 2000; Jeziorski et al., 2000). 
In addition to the α1 subunits, two subtypes of Cavβs have been cloned from 
schistosomes (Kohn et al., 2001a; 2003a). Again, this finding in itself is noteworthy, in that only 
one Cavβ subtype has been identified in the genomes of other invertebrates. One of the 
schistosome Cavβs resembles other invertebrate Cavβs in its size and pattern of conserved 
regions.  The other, a variant subtype which we have named Cavβvar, displays clear similarity to 
the family of Cavβ subunits, but differs in several fundamental ways.  The predicted protein is 
significantly larger than conventional Cavβs, and similarity at the amino acid level in conserved 
regions is markedly reduced, suggesting a separate gene family. Although Cavβvar contains a 
domain similar to the BID of conventional β subunits, it lacks two highly conserved serine 
residues (see Table 1). These conserved serines each constitute consensus protein kinase C 
(PKC) phosphorylation sites.  The Cavβvar subunit was simultaneously cloned from two species 
of schistosomes, S. mansoni (SmCavβvar, formerly called SmCavβA) and S. japonicum 
(SjCavβvar, formerly SjCavβ), but no homologs of the variant subtype could be identified by 
similarity searches in any vertebrate or other invertebrate genome. 
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Studies using heterologous expression revealed that schistosome Cavβvar possesses 
functional properties that are not shared with other Cavβs (Kohn et al., 2001a). The Cavβvar 
subunit associates with α1 subunits when expressed in Xenopus oocytes, as it causes the 
current/voltage relationship of α1 subunits to shift in a hyperpolarizing direction much as 
conventional β subunits do. However, all conventional β subunits studied to date also increase 
the amplitude of the current gated by α1 subunits. In contrast, coexpression of schistosome 
Cavβvar subunits with either a jellyfish (CyCav1) or human (Cav2.3) α1 subunit markedly 
reduces current through the channel. 
Another intriguing aspect of the schistosome Cavβvar subunit is its ability to confer 
praziquantel sensitivity to α1 subunits.  Praziquantel is the drug of choice to treat 
schistosomiasis, due to its efficacy against all schistosome species and relatively benign side 
effect profile (Andrews et al., 1983; Fenwick et al., 2003; Hagan et al., 2004). Although 
praziquantel acts against a wide variety of platyhelminths, it is generally ineffective against other 
organisms such as nematodes (Andrews et al., 1985).  The molecular target of praziquantel has 
not been defined, but it is known to induce rapid influx of Ca2+, leading to a rapid, sustained 
Ca2+-dependent muscular contraction (for reviews see Andrews, 1985; Day et al., 1992; Redman 
et al., 1996; Cioli and Pica-Mattoccia, 2003; Greenberg, 2005). 
 Co-expression of the schistosome Cavβvar subunit with a praziquantel-insensitive 
mammalian α1 subunit (Cav2.3) yields a current that is responsive to praziquantel.  Peak Ca2+ 
currents are increased in the presence of 100 nM praziquantel in Xenopus oocytes coexpressing 
the two subunits, but not with either subunit alone (Kohn et al., 2001a). The praziquantel-
dependent increase in Ca2+ current amplitude is consistent with the reported ability of the drug to 
induce Ca2+ influx. Other Cavβs, including the conventional schistosome β subunit, do not confer 
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praziquantel sensitivity to the mammalian α1 subunit (Kohn et al., 2003b). 
 Site-directed mutagenesis has revealed that the absence of the two consensus PKC sites 
in the BID region of Cavβvar subunits is responsible in part for both the current reduction and the 
ability to confer praziquantel sensitivity (Kohn et al., 2003a, b). Restoring the consensus PKC 
sites in Cavβvar by substituting serine residues at either or both of these sites restores the ability 
of the subunit to enhance currents through α1 subunits like other Cavβs, while sensitivity to 
praziquantel is eliminated. When one such mutant containing a single serine is further altered to 
eliminate a basic residue and disrupt the consensus PKC site, the phenotype reverts to that of the 
wildtype schistosome Cavβvar. Thus, the novel effects of the variant subunit result from a lack of 
PKC sites in the BID rather than the absence of serines.  The importance of PKC sites within the 
BID of Cavβvar is consistent with the finding that phosphorylation of VGCC subunits is a critical 
regulator of channel properties (reviewed by Rossie, 1999; Kamp and Hell, 2000; Keef et al., 
2001). Although recombinant mammalian β subunits can be phosphorylated by PKC in vitro 
(Puri et al., 1997), the specific sites of phosphorylation have not yet been determined. 
 In recent years, several reports of schistosome isolates with reduced susceptibility to 
praziquantel have appeared (reviewed by Cioli et al., 1993; Day and Botros, 2006; Brindley, 
1994; Geerts and Gryseels, 2001). The finding that a single-base mutation at a critical site can 
eliminate the ability of Cavβvar to confer praziquantel sensitivity might suggest such a 
mechanism for acquiring praziquantel resistance. S. mansoni strains reported to have reduced 
praziquantel sensitivity show no changes in primary structure or expression levels of schistosome 
β subunits (Valle et al. 2003). However, Egyptian isolates with reduced praziquantel 
susceptibility show differential stability and reproductive fitness, which may indicate that there 
are several pathways for acquiring reduced sensitivity to praziquantel (William et al., 2001b), 
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and schistosomes may make use of more than one mechanism. 
 If the variant β subunit found in schistosomes is in fact an essential target of praziquantel, 
the Cavβvar gene should be found in other organisms that exhibit sensitivity to the drug.  An 
important target of praziquantel is Taenia solium, the pork tapeworm, which represents a 
significant health problem in developing countries (Carpio et al., 2002; Flisser et al., 2003; 
Garcia et al., 2003). Praziquantel is effective in treating both the intermediate porcine host and 
humans infected with either cysticerci or adult T. solium (Andrews et al., 1983; Cioli and Pica-
Mattoccia, 2003; Garcia et al., 2003). As in schistosomes, the precise manner in which 
praziquantel acts upon Taenia has not been extensively studied. 
 
4. Variant Cavβs in Taenia solium and other platyhelminths. 
 We used reverse transcription of RNA plus PCR (RT-PCR) to search for β subunit 
homologs in T. solium cysticerci obtained from muscle tissue of an infected pig (Veterinary 
School, Universidad Nacional Autónoma de México). Using degenerate primers designed against 
conserved regions of β subunit genes, we amplified fragments of two distinct β subunit cDNAs 
from T. solium, and the full cDNAs were then isolated via standard cloning techniques and 
sequenced.  
 One cDNA, named TsCavβ, is 2249 bp long and encodes a protein of 640 amino acids 
with a predicted molecular weight of 72.5 kDa that resembles the conventional β subunits found 
in S. mansoni and in many other invertebrate and vertebrate organisms (Fig. 2A). The second 
cDNA, TsCavβvar, more closely resembles SmCavβvar and SjCavβvar, the variant β subunits 
identified only in schistosomes to date. The cloned TsCavβvar cDNA is 2772 bp in length and 
contains an open reading frame encoding a protein of 809 amino acids with a predicted 
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molecular weight of 86.6 kDa (Fig. 2B). Two spliced forms of the TsCavβvar cDNA were 
isolated during the process of cloning. One lacks a cassette of 18 amino acids between residues 
684-701 within an unconserved region near the carboxyl terminus. A second cDNA lacks the 
133 amino acids between residues 391-523, including a segment that is moderately conserved 
with the schistosome subunits. Although neither of the two alternate cDNAs is a product of 
mispriming during PCR, it is still unclear whether they represent splicing artifacts or functionally 
relevant mRNAs. 
 Phylogenetic analysis reveals that the conventional and variant β subunits form two 
subfamilies that are related but separate (Fig. 3). As described above, an important structural 
distinction between the two types of subunits resides within the BID, in which variant β subunits 
lack two conserved PKC sites. TsCavβ differs from other conventional β subunits by containing 
threonine in place of the first serine, but threonine can also be phosphorylated by PKC 
(Woodgett et al., 1986). In both SmCavβvar and SjCavβvar, the two serines are replaced by 
cysteine and alanine. Within the TsCavβvar sequence the serines are replaced by asparagine and 
alanine (Table 1), which is consistent with the BIDs of the variant schistosome subunits. As in 
SmCavβvar and SjCavβvar, the remainder of the BID is conserved with respect to conventional β 
subunits. 
 We investigated whether variant β subunits are found in other classes of platyhelminths 
by screening two turbellarians for β subunit BID regions. Adapter-ligated, amplified cDNA pools 
(Matz, 2002) were generated from Dugesia dorotocephala (Carolina Biological Supply) and 
Bdelloura candida (collected from the legs and gills of Limulus polyphemus maintained at the 
Whitney Laboratory, University of Florida). cDNA fragments amplified as described in Fig. 2 
from each species encoded a BID lacking the two serine residues. As in the variant schistosome 
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subunits, the turbellarian sequences incorporate cystine and alanine residues in the corresponding 
positions (Table 1). A second fragment resembling the BIDs of conventional β subunits was also 
amplified from B. candida, indicating that both forms of the β subunit are expressed in three 
different classes of platyhelminths. 
 These findings demonstrate that a homolog of the variant β subunits identified in the 
trematodes S. mansoni and S. japonicum is also expressed in the cestode T. solium, as well as in 
two species of turbellarians. Although it remains to be determined whether a homologous protein 
is found in all platyhelminths, our results establish a stronger correlation between the presence of 
the βvar subtype and sensitivity to praziquantel.  As noted above, the βvar isoform may be 
unique to platyhelminths, as no sequence resembling that of variant Cavβs has yet been found 
outside of the phylum. For example, only a single, conventional β subtype has been found in the 
mollusc Lymnaea stagnalis (Spafford et al., 2003). Furthermore, a thorough BLAST search for β 
subunit homologues within the fully sequenced genomes of C. elegans, D. melanogaster, and 
Ciona intestinalis detects only a single conventional β subunit in each. A distant homolog of 
known β subunits is present in some genomes (e.g. the w10c8.1 gene in C. elegans), but the 
translated sequence deviates significantly from both β subunits described here, and the C. 
elegans protein appears not to modulate α1 subunits when expressed in Xenopus oocytes (M.C. 
Jeziorski, unpublished observations). 
 
5. Conclusions 
 The results presented here provide further evidence for the hypothesis that a variant β 
subunit of VGCCs is the clinically relevant target of praziquantel in schistosomes and other 
platyhelminths.  Heterologous expression has demonstrated that the Cavβvar subunit can 
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associate with an α1 subunit, induce alterations in channel kinetics and current amplitude, and 
confer sensitivity to praziquantel in a normally insensitive subunit.  The increase in Ca2+ current 
in such channels in the presence of praziquantel is consistent with previously described 
physiological effects of the drug.  Conserved PKC sites that exist in all known conventional Cavβ 
subunits, but in no Cavβvar subunits, account for the differential responses of the two families of 
subunits to praziquantel.  We now show that the Cavβvar subunit is not limited to schistosomes, 
but is also found in Taenia solium, an important clinical target of praziquantel, as well as two 
species from a third class of platyhelminths.  To date, the presence or absence of the Cavβvar 
subunit in a given organism is consistently correlated with the presence or absence of sensitivity 
to praziquantel. 
 Nevertheless, several key questions remain before the Cavβvar subunit can be definitively 
established as the essential target of praziquantel.  Due to technical obstacles in expressing 
cloned schistosome α1 subunits, the effects of the Cavβvar subunit have been studied only upon 
non-helminthic channels.  We do not yet know whether Cavβvar associates with one or all of the 
α1 subunits present in schistosomes, or whether the association is limited to L-type, non-L-type, 
or as yet undescribed T-type (LVA) channels.  Furthermore, it is not clear whether Cavβvar 
competes with the conventional Cavβ subunit, or whether the two have complementary or 
exclusive roles in modulating trafficking, kinetic response, or pharmacology of the α1 subunit. 
Cavβvar may associate with multiple α1 subunits, but induce praziquantel sensitivity in only a 
subset.  In addition, the precise mechanism of praziquantel interaction with Ca2+ channel 
subunits remains unresolved. Does it interact directly with the β subunit, interfere with α1/β 
interaction, or act indirectly on Ca2+ channels containing these variant Cavβs?  
14 
 Beyond the questions related to praziquantel sensitivity are the biological roles these 
variant Cavβs play in platyhelminths. The growing evidence that the Cavβvar subunit is a 
platyhelminth-specific family of β subunits raises intriguing issues about their importance to 
helminth physiology.  Unlike other β subunits, the variant β subunits reduce Ca2+ currents in 
oocytes instead of increasing them. If this response is true of native schistosome currents, what is 
the importance of this unusual type of modulation? Are these β subunits interacting with other 
receptors or channels? Genomic, post-genomic, and physiological studies may allow some of 
these questions to be addressed directly. 
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FIGURE LEGENDS 
Figure 1. Simplified structure of a vertebrate voltage-gated Ca2+ channel. Subunits include the 
pore-forming α1 subunit, which consists of four homologous domains surrounding a central pore. 
Each domain comprises six transmembrane regions (S1-S6). The P loop which dips into the 
membrane between S5 and S6 forms the selectivity filter of the channel. The S4 transmembrane 
region contains a series of regularly spaced, positively charged residues (+) and is thought to 
form the voltage sensor of the channel. Also shown are auxiliary β, α2δ, and γ subunits, which 
modulate α1 function. β and α2δ subunit homologs have been identified in schistosomes.  
Domains of the β subunit defined by recent homology modeling and high resolution structural 
analysis (see text) are shown. The β subunit interacts via its guanylate kinase (GK) domain with 
the Alpha Interaction Domain (AID) on the I-II loop of the α1 subunit. Size of subunits and 
domains are not to scale. Adapted from elements of Randall and Benham (1999) and Yue (2004). 
Figure 2. A. Alignment of the conventional T. solium β subunit TsCavβ with the S. mansoni 
subunit SmCavβ. B. Alignment of the variant T. solium β subunit TsCavβvar with the S. mansoni 
subunit SmCavβvar. Residues that are identical between sequences are shaded. The position of 
the β interaction domain is indicated in each figure, and the locations of two deletions identified 
in certain TsCavβvar clones are indicated by dashed lines. The alignments were completed using 
Clustal W 1.82. To clone the two T. solium cDNAs, RNA was extracted from T. solium 
cysticerci with TRIzol and reverse-transcribed with SuperScript II reverse transcriptase 
(Invitrogen) and an oligo-dT primer. Touchdown PCR with the degenerate oligonucleotides 
AAYAAYGAYGGTGGAT and GCYTTYTGCATCATRTC [94° for 30 sec, 49° for 40 sec 
(minus 0.5°/cycle), 72° for 30 sec for 22 cycles, followed by an additional 30 cycles using a 42° 
annealing temperature] generated two distinct cDNA fragments. The amplified products were 
28 
cloned into the pTOPO II vector (Invitrogen) and sequenced on an automated sequencer. The 
cDNA ends were amplified using 3′RACE and 5′RACE (Frohman et al., 1988), and the full 
coding region of each cDNA was determined. For each of the two subunits, multiple cDNAs 
were cloned from separate sources and sequenced to establish a consensus sequence. The 
GenBank accession numbers are AY624029 for TsCavβ, AY624030 for TsCavβvar, AAK51118 
for SmCavβB, and AAK51117 for SmCavβvar. 
Figure 3. Phylogenetic relationships among conventional and variant Ca2+  channel β subunits, 
including the distant C. elegans β subunit homolog w10c8.1. The tree was constructed using the 
neighbor-joining method as implemented in MEGA 3.1 (Kumar et al., 2004). Bootstrap values 
from 100 replicates are shown. The GenBank accession numbers for the sequences are as 
follows: S. japonicum βvar, AY033597; human β1, NP_954856; rabbit β1, AAA31180; human 
β2, AAD33730; rabbit β2, P54288; human β3, AAA19799; rabbit β3, CAA45578; human β4, 
AAB53333; rat β4, A45982; Xenopus β3, AAA75519; Fugu β3, AAB96361; Caenorhabditis 
elegans, AAB53056; Musca, A54844; Drosophila, AAF21096; Loligo, BAB88219; Lymnaea, 
AAO83844; Cyanea, AAB87751; and C. elegans w10c8.1, AAK21500. 
 
 
 
 Table 1.  Alignment of a conserved region of the β interaction domains of conventional and variant β subunits 
 
Conventional β subunits 
Subtype or species  Phylum                         *                   * 
human β1   Chordata  P P Y D V V P S M R P I I L V G P S L K G Y E V T 
human β2   Chordata  P P Y D V V P S M R P V V L V G P S L K G Y E V T 
human β3   Chordata  P P Y D V V P S M R P V V L V G P S L K G Y E V T 
human β4   Chordata  P P Y D V V P S M R P V V L V G P S L K G Y E V T 
Loligo bleekeri  Mollusca  P P Y E V V P S M R P V V L I G P S L K G Y E V T 
Lymnaea stagnalis  Mollusca  P P Y E V V P S M R P V V L I G P S L K G Y E V T 
Musca domestica  Arthropoda  S P Y D V V P S M R P V V L V G P S L K G Y E V T 
Drosophila melanogaster Arthropoda  S P Y D V V P S M R P V V L V G P S L K G Y E V T 
Caenorhabditis elegans Nematoda  P P Y D V V P S M R P V V L V G P S L K G Y E V T 
Cyanea capillata  Cnidaria  P P Y D V V P S M R P V I F V G P S L K G Y E V T 
Schistosoma mansoni  Platyhelminthes P P Y D V V P S M R P V V L I G P S L K G Y E V T 
Taenia solium   Platyhelminthes P P Y E V V P T M R P V V L I G P S L K G Y E V T 
Bdelloura candida  Platyhelminthes  P P Y E V V P S M R P V V L I G P S L K G Y E V T 
 
Variant β subunits 
Platyhelminth species  Class 
Schistosoma mansoni  Trematoda  P P Y E I V P C M R P V V F V G P A L K G Y E V T 
Schistosoma japonicum Trematoda  P P Y E I V P C M R P V V F V G P A L K G Y E V T 
Taenia solium   Cestoda  P P Y E L V P N V R P V V V V G P A L K G Y E V T 
Bdelloura candida  Turbellaria  P P Y E I V P C M R P V I F L G P A L K G F E V T 
Dugesia dorotocephala Turbellaria  P P Y D V V P C M R P I I L V G P A L K G Y E V T 
 
*consensus sites for protein kinase C phosphorylation in conventional β subunits 
Table 1
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